Orfenace Tablet 100mg(2021-04-13)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Orfenace Tablets 100mg
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 10025A18,10025B18,10025A19,36664, 37342,37384,38058 | Orfenace Tablet 100mg | - Recalling Firm
- Sterimax Inc.
- 2770 Portland Drive
- Oakville
- L6H 6R4
- Ontario
- CANADA
- Marketing Authorization Holder
- Sterimax Inc.
- 2770 Portland Drive
- Oakville
- L6H 6R4
- Ontario
- CANADA
| DIN 02047535 | Tablet | Orphenadrine Citrate 100mg |
Presence of N-methyl-N-nitroso-2-[(2-methylphenyl)phenylmethoxy]ethanamine (NMOA) above the acceptable concentration limit in affected lots.